Ρεμντεσιβίρη (Greek Wikipedia)
Analysis of information sources in references of the Wikipedia article "Ρεμντεσιβίρη" in Greek language version.
refsWebsite
Global rank
Greek rank
5,225th place
7,320th place
1st place
1st place
3,823rd place
2,141st place
49th place
98th place
8,771st place
low place
18th place
57th place
800th place
4,641st place
3,984th place
2,133rd place
17th place
525th place
low place
low place
7th place
29th place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
99th place
261st place
asahi.com
- «Japan approves remdesivir for COVID-19 despite uncertainties». The Asahi Shimbun. 8 Μαΐου 2020. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Μαΐου 2020. Ανακτήθηκε στις 9 Μαΐου 2020.
bbc.com
- Roberts, Michelle (26 May 2020). «Anti-viral drug that speeds recovery offered by NHS». BBC News Online. https://www.bbc.com/news/health-52805828. Ανακτήθηκε στις 26 May 2020.
bloomberg.com
- Wilson J. (July 30, 2020). "Remdesivir Gets Lukewarm Endorsement From Experts in Covid Fight". Bloomberg. Retrieved 31 July 2020.
bmj.com
- «Remdesivir in covid-19». BMJ 369: m1610. April 2020. doi:. PMID 32321732. https://www.bmj.com/content/369/bmj.m1610.long.
clinicaltrials.gov
- «7 Studies found for: Remdesivir & Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation Studies & COVID-19». ClinicalTrials.gov. U.S. National Library of Medicine. Ανακτήθηκε στις 16 Απριλίου 2020.
- «A Trial of Remdesivir in Adults With Severe COVID-19». ClinicalTrials.gov. 6 Φεβρουαρίου 2020. Ανακτήθηκε στις 19 Απριλίου 2020.
- «A Trial of Remdesivir in Adults With Mild and Moderate COVID-19». ClinicalTrials.gov. 5 Φεβρουαρίου 2020. Ανακτήθηκε στις 19 Απριλίου 2020.
- «Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment». ClinicalTrials.gov. 3 Μαρτίου 2020. Ανακτήθηκε στις 19 Απριλίου 2020.
- «Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Severe Coronavirus Disease (COVID-19)». ClinicalTrials.gov. 3 Μαρτίου 2020. Ανακτήθηκε στις 19 Απριλίου 2020.
- «Trial of Treatments for COVID-19 in Hospitalized Adults (DisCoVeRy)». ClinicalTrials.gov. 20 Μαρτίου 2020. Ανακτήθηκε στις 19 Απριλίου 2020.
- «Expanded Access Remdesivir (RDV; GS-5734)». ClinicalTrials.gov. 10 Μαρτίου 2020. Ανακτήθηκε στις 19 Απριλίου 2020.
- «Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)». ClinicalTrials.gov. 27 Μαρτίου 2020. Ανακτήθηκε στις 19 Απριλίου 2020.
- «Adaptive COVID-19 Treatment Trial (ACTT)». ClinicalTrials.gov. 21 Φεβρουαρίου 2020. Ανακτήθηκε στις 11 Μαΐου 2020.
- «Adaptive COVID-19 Treatment Trial 3 (ACTT-3)». ClinicalTrials.gov. 30 Ιουλίου 2020. Ανακτήθηκε στις 5 Αυγούστου 2020.
clinicaltrialsregister.eu
- «Multi-centre, adaptive, randomized trial of the safety and efficacy of treatments of COVID-19 in hospitalized adults (DisCoVeRy)». European Union Clinical Trials Register. Ανακτήθηκε στις 19 Απριλίου 2020.
covid19-druginteractions.org
- «COVID-19 interactions». University of Liverpool. Ανακτήθηκε στις 28 Απριλίου 2020.
doi.org
dx.doi.org
- «Current pharmacological treatments for COVID-19: What's next?». British Journal of Pharmacology. April 2020. doi:. PMID 32329520.
- «Pharmacotherapy in COVID-19; A narrative review for emergency providers». The American Journal of Emergency Medicine 38 (7): 1488–1493. July 2020. doi:. PMID 32336586.
- Beigel, John H.; Tomashek, Kay M.; Dodd, Lori E.; Mehta, Aneesh K.; Zingman, Barry S.; Kalil, Andre C.; Hohmann, Elizabeth; Chu, Helen Y. και άλλοι. (2020-05-22). «Remdesivir for the Treatment of Covid-19 — Final Report» (στα αγγλικά). New England Journal of Medicine. doi:. PMID 32445440. PMC PMC7262788. https://www.nejm.org/doi/10.1056/NEJMoa2007764.
- «Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys». Nature 531 (7594): 381–5. March 2016. doi:. PMID 26934220. Bibcode: 2016Natur.531..381W.
- «Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19». ACS Central Science 6 (5): 672–683. May 2020. doi:. PMID 32483554.
- «Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses». Science Translational Medicine 9 (396): eaal3653. June 2017. doi:. PMID 28659436.
- «Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency». The Journal of Biological Chemistry 295 (20): 6785–6797. May 2020. doi:. PMID 32284326.
- «Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides». Bioorganic & Medicinal Chemistry Letters 22 (8): 2705–7. April 2012. doi:. PMID 22446091.
- «Remdesivir in covid-19». BMJ 369: m1610. April 2020. doi:. PMID 32321732. https://www.bmj.com/content/369/bmj.m1610.long.
- «Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir». Viruses 11 (4): 326. April 2019. doi:. PMID 30987343.
- «The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus». The Journal of Biological Chemistry 295 (15): 4773–4779. April 2020. doi:. PMID 32094225.
- Yan, Victoria C.; Muller, Florian L. (July 2020). «Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment». ACS Medicinal Chemistry Letters 11 (7): 1361–1366. doi:. PMID 32665809.
- «GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses». Scientific Reports 7: 43395. March 2017. doi:. PMID 28262699. Bibcode: 2017NatSR...743395L.
- «Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19». ACS Central Science 6 (5): 672–683. May 2020. doi:. PMID 32483554.
- «Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence». Travel Medicine and Infectious Disease 35: 101647. April 2020. doi:. PMID 32247927.
- «Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection». Proceedings of the National Academy of Sciences of the United States of America 117 (12): 6771–6776. March 2020. doi:. PMID 32054787.
- «Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses». Science Translational Medicine 9 (396): eaal3653. June 2017. doi:. PMID 28659436.
- «Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial». Lancet 395 (10236): 1569–1578. May 2020. doi:. PMID 32423584.
- Kupferschmidt, Kai; Cohen, Jon (22 March 2020). «WHO launches global megatrial of the four most promising coronavirus treatments». Science. doi:.
- «Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2». Nature 585 (7824): 273–276. June 2020. doi:. PMID 32516797.
drugs.com
- «Remdesivir». Drugs.com. 20 Απριλίου 2020. Ανακτήθηκε στις 30 Απριλίου 2020.
espacenet.com
worldwide.espacenet.com
europa.eu
ema.europa.eu
- «Veklury EPAR». European Medicines Agency (EMA). 23 Ιουνίου 2020. Ανακτήθηκε στις 6 Ιουλίου 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- «Summary on Compassionate Use: Remdesivir Gilead» (PDF). European Medicines Agency (EMA). 3 Απριλίου 2020. Ανακτήθηκε στις 1 Μαΐου 2020.
fda.gov
- «Remdesivir EUA Letter of Authorization» (PDF). U.S. Food and Drug Administration (FDA). 1 Μαΐου 2020. Ανακτήθηκε στις 1 Μαΐου 2020.
Αυτό το λήμμα περιλαμβάνει κείμενο από αυτή την πηγή, που είναι κοινό κτήμα. - «Fact Sheet for Patients And Parent/Caregivers Emergency Use Authorization (EUA) Of Remdesivir For Coronavirus Disease 2019 (COVID-19)» (PDF). U.S. Food and Drug Administration (FDA). Ανακτήθηκε στις 8 Μαΐου 2020.
- «Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of Remdesivir (GS-5734TM)» (PDF). U.S. Food and Drug Administration (FDA). 15 Ιουνίου 2020. Ανακτήθηκε στις 15 Ιουνίου 2020. Αυτό το λήμμα περιλαμβάνει κείμενο από αυτή την πηγή, που είναι κοινό κτήμα.
gilead.com
- «Remdesivir Clinical Trials». Gilead Sciences. Ανακτήθηκε στις 20 Απριλίου 2020.
harvard.edu
adsabs.harvard.edu
- «Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys». Nature 531 (7594): 381–5. March 2016. doi:. PMID 26934220. Bibcode: 2016Natur.531..381W.
- «GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses». Scientific Reports 7: 43395. March 2017. doi:. PMID 28262699. Bibcode: 2017NatSR...743395L.
hopkinsguides.com
- «Coronavirus COVID-19 (SARS-CoV-2)». Johns Hopkins ABX Guide. Ανακτήθηκε στις 12 Απριλίου 2020.
Remdesivir: Likely the most promising drug.
indiatimes.com
timesofindia.indiatimes.com
- «India approves emergency use of remdesivir to treat Covid-19 patients». The Times of India. Reuters (Gurgaon, Haryana, India: Times Internet). 2 June 2020. https://timesofindia.indiatimes.com/india/india-approves-emergency-use-of-remdesivir-to-treat-covid-19-patients/articleshow/76152949.cms. Ανακτήθηκε στις 2 June 2020.
inserm.fr
presse.inserm.fr
- «Launch of a European clinical trial against COVID-19». INSERM. 22 Μαρτίου 2020. Ανακτήθηκε στις 1 Μαΐου 2020.
keionline.org
- Ardizzone, Kathryn (20 March 2020). «Role of the Federal Government in the Development of Remdesivir». Knowledge Ecology International. https://www.keionline.org/wp-content/uploads/KEI-Briefing-Note-2020_1GS-5734-Remdesivir.pdf. Ανακτήθηκε στις 28 May 2020.
medicines.org.uk
- «Veklury 100 mg concentrate for solution for infusion - Summary of Product Characteristics (SmPC)». (emc). 6 Ιουλίου 2020. Αρχειοθετήθηκε από το πρωτότυπο στις 24 Νοεμβρίου 2020. Ανακτήθηκε στις 4 Οκτωβρίου 2020.
- «Veklury 100 mg powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC)». (emc). Ανακτήθηκε στις 4 Οκτωβρίου 2020.
nejm.org
- Beigel, John H.; Tomashek, Kay M.; Dodd, Lori E.; Mehta, Aneesh K.; Zingman, Barry S.; Kalil, Andre C.; Hohmann, Elizabeth; Chu, Helen Y. και άλλοι. (2020-05-22). «Remdesivir for the Treatment of Covid-19 — Final Report» (στα αγγλικά). New England Journal of Medicine. doi:. PMID 32445440. PMC PMC7262788. https://www.nejm.org/doi/10.1056/NEJMoa2007764.
nih.gov
ncbi.nlm.nih.gov
- «Current pharmacological treatments for COVID-19: What's next?». British Journal of Pharmacology. April 2020. doi:. PMID 32329520.
- «Pharmacotherapy in COVID-19; A narrative review for emergency providers». The American Journal of Emergency Medicine 38 (7): 1488–1493. July 2020. doi:. PMID 32336586.
- Beigel, John H.; Tomashek, Kay M.; Dodd, Lori E.; Mehta, Aneesh K.; Zingman, Barry S.; Kalil, Andre C.; Hohmann, Elizabeth; Chu, Helen Y. και άλλοι. (2020-05-22). «Remdesivir for the Treatment of Covid-19 — Final Report» (στα αγγλικά). New England Journal of Medicine. doi:. PMID 32445440. PMC PMC7262788. https://www.nejm.org/doi/10.1056/NEJMoa2007764.
- «Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys». Nature 531 (7594): 381–5. March 2016. doi:. PMID 26934220. Bibcode: 2016Natur.531..381W.
- «Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19». ACS Central Science 6 (5): 672–683. May 2020. doi:. PMID 32483554.
- «Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses». Science Translational Medicine 9 (396): eaal3653. June 2017. doi:. PMID 28659436.
- «Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency». The Journal of Biological Chemistry 295 (20): 6785–6797. May 2020. doi:. PMID 32284326.
- «Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides». Bioorganic & Medicinal Chemistry Letters 22 (8): 2705–7. April 2012. doi:. PMID 22446091.
- «Remdesivir in covid-19». BMJ 369: m1610. April 2020. doi:. PMID 32321732. https://www.bmj.com/content/369/bmj.m1610.long.
- «Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir». Viruses 11 (4): 326. April 2019. doi:. PMID 30987343.
- «The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus». The Journal of Biological Chemistry 295 (15): 4773–4779. April 2020. doi:. PMID 32094225.
- Yan, Victoria C.; Muller, Florian L. (July 2020). «Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment». ACS Medicinal Chemistry Letters 11 (7): 1361–1366. doi:. PMID 32665809.
- «GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses». Scientific Reports 7: 43395. March 2017. doi:. PMID 28262699. Bibcode: 2017NatSR...743395L.
- «Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19». ACS Central Science 6 (5): 672–683. May 2020. doi:. PMID 32483554.
- «Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence». Travel Medicine and Infectious Disease 35: 101647. April 2020. doi:. PMID 32247927.
- «Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection». Proceedings of the National Academy of Sciences of the United States of America 117 (12): 6771–6776. March 2020. doi:. PMID 32054787.
- «Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses». Science Translational Medicine 9 (396): eaal3653. June 2017. doi:. PMID 28659436.
- «Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial». Lancet 395 (10236): 1569–1578. May 2020. doi:. PMID 32423584.
- «Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2». Nature 585 (7824): 273–276. June 2020. doi:. PMID 32516797.
pubmedcentral.nih.gov
- «Current pharmacological treatments for COVID-19: What's next?». British Journal of Pharmacology. April 2020. doi:. PMID 32329520.
- «Pharmacotherapy in COVID-19; A narrative review for emergency providers». The American Journal of Emergency Medicine 38 (7): 1488–1493. July 2020. doi:. PMID 32336586.
- Beigel, John H.; Tomashek, Kay M.; Dodd, Lori E.; Mehta, Aneesh K.; Zingman, Barry S.; Kalil, Andre C.; Hohmann, Elizabeth; Chu, Helen Y. και άλλοι. (2020-05-22). «Remdesivir for the Treatment of Covid-19 — Final Report» (στα αγγλικά). New England Journal of Medicine. doi:. PMID 32445440. PMC PMC7262788. https://www.nejm.org/doi/10.1056/NEJMoa2007764.
- «Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys». Nature 531 (7594): 381–5. March 2016. doi:. PMID 26934220. Bibcode: 2016Natur.531..381W.
- «Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19». ACS Central Science 6 (5): 672–683. May 2020. doi:. PMID 32483554.
- «Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses». Science Translational Medicine 9 (396): eaal3653. June 2017. doi:. PMID 28659436.
- «Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency». The Journal of Biological Chemistry 295 (20): 6785–6797. May 2020. doi:. PMID 32284326.
- «Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides». Bioorganic & Medicinal Chemistry Letters 22 (8): 2705–7. April 2012. doi:. PMID 22446091.
- «Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir». Viruses 11 (4): 326. April 2019. doi:. PMID 30987343.
- «The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus». The Journal of Biological Chemistry 295 (15): 4773–4779. April 2020. doi:. PMID 32094225.
- Yan, Victoria C.; Muller, Florian L. (July 2020). «Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment». ACS Medicinal Chemistry Letters 11 (7): 1361–1366. doi:. PMID 32665809.
- «GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses». Scientific Reports 7: 43395. March 2017. doi:. PMID 28262699. Bibcode: 2017NatSR...743395L.
- «Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19». ACS Central Science 6 (5): 672–683. May 2020. doi:. PMID 32483554.
- «Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence». Travel Medicine and Infectious Disease 35: 101647. April 2020. doi:. PMID 32247927.
- «Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection». Proceedings of the National Academy of Sciences of the United States of America 117 (12): 6771–6776. March 2020. doi:. PMID 32054787.
- «Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses». Science Translational Medicine 9 (396): eaal3653. June 2017. doi:. PMID 28659436.
- «Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial». Lancet 395 (10236): 1569–1578. May 2020. doi:. PMID 32423584.
- «Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2». Nature 585 (7824): 273–276. June 2020. doi:. PMID 32516797.
dailymed.nlm.nih.gov
- «Remdesivir injection Remdesivir injection, powder, lyophilized, for solution». DailyMed. 1 Σεπτεμβρίου 2020. Ανακτήθηκε στις 25 Σεπτεμβρίου 2020.
nytimes.com
- Stephens, Bret (18 April 2020). «The Story of Remdesivir». The New York Times: σελ. A23. https://www.nytimes.com/2020/04/17/opinion/remdesivir-coronavirus.html. Ανακτήθηκε στις 11 May 2020.
reuters.com
- «Singapore approves remdesivir drug for emergency COVID-19 treatment». Reuters. 10 Ιουνίου 2020. Ανακτήθηκε στις 10 Ιουνίου 2020.
- Joseph, Saumya Sibi; Samuel, Maju (31 January 2020). «Gilead working with China to test Ebola drug as new coronavirus treatment». Reuters. Αρχειοθετήθηκε από το πρωτότυπο στις 31 January 2020. https://web.archive.org/web/20200131201118/https://www.reuters.com/article/us-health-china-gilead-sciences/gilead-working-with-china-to-test-ebola-drug-as-new-coronavirus-treatment-idUSKBN1ZU2RX. Ανακτήθηκε στις 31 January 2020.
rmx.news
- Czech News Agency, "Did Czech scientists create the cure for coronavirus?", Aktuálně.cz, 5 February 2020.
sfist.com
- Barmann, Jay (6 February 2020). «Bay Area-Based Gilead Sees Potential Legal Conflict With China Over Its Coronavirus Drug». SFist. Impress Media. Αρχειοθετήθηκε από το πρωτότυπο στις 26 March 2020. https://web.archive.org/web/20200326060714/https://sfist.com/2020/02/06/bay-area-based-gilead-donates-experimental-anti-viral-drug-to-china/. Ανακτήθηκε στις 22 March 2020.
statnews.com
- Yan, Victoria C.· Muller, Florian L. (14 Μαΐου 2020). «Gilead should ditch remdesivir and focus on its simpler and safer ancestor». Stat. Boston Globe Media Partners.
- Silverman, Ed (8 Μαΐου 2020). «U.S. government contributed research to a Gilead remdesivir patent – but didn't get credit». Stat. Ανακτήθηκε στις 28 Μαΐου 2020.
tga.gov.au
tga.gov.au
- «Veklury Australian prescription medicine decision summary». Therapeutic Goods Administration (TGA). 13 Ιουλίου 2020. Αρχειοθετήθηκε από το πρωτότυπο στις 13 Αυγούστου 2020. Ανακτήθηκε στις 16 Αυγούστου 2020.
ebs.tga.gov.au
- «Summary for ARTG Entry:338419 Veklury remdesivir 100 mg powder for injection vial». Therapeutic Goods Administration (TGA). Ανακτήθηκε στις 16 Αυγούστου 2020.[νεκρός σύνδεσμος]
uab.edu
- «Investigational compound remdesivir, developed by UAB and NIH researchers, being used for treatment of novel coronavirus». UAB News. Ανακτήθηκε στις 28 Μαΐου 2020.
un.org
news.un.org
- «UN health chief announces global 'solidarity trial' to jumpstart search for COVID-19 treatment». UN News. 18 Μαρτίου 2020.
web.archive.org
- «Veklury Australian prescription medicine decision summary». Therapeutic Goods Administration (TGA). 13 Ιουλίου 2020. Αρχειοθετήθηκε από το πρωτότυπο στις 13 Αυγούστου 2020. Ανακτήθηκε στις 16 Αυγούστου 2020.
- «Veklury 100 mg concentrate for solution for infusion - Summary of Product Characteristics (SmPC)». (emc). 6 Ιουλίου 2020. Αρχειοθετήθηκε από το πρωτότυπο στις 24 Νοεμβρίου 2020. Ανακτήθηκε στις 4 Οκτωβρίου 2020.
- «Japan approves remdesivir for COVID-19 despite uncertainties». The Asahi Shimbun. 8 Μαΐου 2020. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Μαΐου 2020. Ανακτήθηκε στις 9 Μαΐου 2020.
- Joseph, Saumya Sibi; Samuel, Maju (31 January 2020). «Gilead working with China to test Ebola drug as new coronavirus treatment». Reuters. Αρχειοθετήθηκε από το πρωτότυπο στις 31 January 2020. https://web.archive.org/web/20200131201118/https://www.reuters.com/article/us-health-china-gilead-sciences/gilead-working-with-china-to-test-ebola-drug-as-new-coronavirus-treatment-idUSKBN1ZU2RX. Ανακτήθηκε στις 31 January 2020.
- Barmann, Jay (6 February 2020). «Bay Area-Based Gilead Sees Potential Legal Conflict With China Over Its Coronavirus Drug». SFist. Impress Media. Αρχειοθετήθηκε από το πρωτότυπο στις 26 March 2020. https://web.archive.org/web/20200326060714/https://sfist.com/2020/02/06/bay-area-based-gilead-donates-experimental-anti-viral-drug-to-china/. Ανακτήθηκε στις 22 March 2020.
who.int
- «"Solidarity" clinical trial for COVID-19 treatments». World Health Organization (WHO). 3 Μαρτίου 2020. Ανακτήθηκε στις 19 Απριλίου 2020.
wikipedia.org
cs.wikipedia.org
- Czech News Agency, "Did Czech scientists create the cure for coronavirus?", Aktuálně.cz, 5 February 2020.